LOGIN  |  REGISTER

Recent Insider Transactions - Crinetics Pharmaceuticals (NASDAQ: CRNX)

Follow NASDAQ:CRNX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CRNX Crinetics Pharmaceuticals
Betz Stephen F. / officer: Chief Scientific Officer
06/12/2025
Buy
$9.28
16,645
$154K
197,196
NASDAQ CRNX Crinetics Pharmaceuticals
Betz Stephen F. / officer: Chief Scientific Officer
06/12/2025
Buy
$1.91
71,525
$137K
180,551
NASDAQ CRNX Crinetics Pharmaceuticals
Betz Stephen F. / officer: Chief Scientific Officer
06/12/2025
Sell
$1.91
71,525
$137K
108,514
NASDAQ CRNX Crinetics Pharmaceuticals
Betz Stephen F. / officer: Chief Scientific Officer
06/12/2025
Sell
$32.23
97,483
$3.142M
99,713
NASDAQ CRNX Crinetics Pharmaceuticals
Betz Stephen F. / officer: Chief Scientific Officer
06/12/2025
Sell
$9.28
16,645
$154K
58,198
NASDAQ CRNX Crinetics Pharmaceuticals
Deardorf Caren / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
Okey Stephanie / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
Vivaldi Coelho Rogerio / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
Fust Matthew K / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
Bedrosian Camille L / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
Nichols Weston / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350
NASDAQ CRNX Crinetics Pharmaceuticals
WIERENGA WENDALL / director
06/11/2025
Buy
$32.33
10,350
$335K
10,350

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous